Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Mobility-Shift Assay from US Patent US12071408: "Multi-targeted tyrosine kinase inhibitors effective in antitumor uses"
Assay data:3 Active, 1 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a FGFR4
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (LanthaScreen Eu Kinase Binding Assay) EUB0001632a FGFR3
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a FGFR3
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a FGFR2
Selectivity interaction (LanthaScreen Eu Kinase Binding Assay) EUB0001632a FGFR1
Selectivity interaction (Kinase panel (Z-LYTE Assay)) EUB0001632a FGFR1
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b FGFR4
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b FGFR3
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b FGFR2
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001326b FGFR1
Selectivity interaction (Radiometric kinase assay) EUB0001326b FGFR1
Selectivity interaction (KinomeScan (DiscoverX)) EUB0001619a FGFR4
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on